• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项为期10年的研究揭示了慢性肺曲霉病“半侵袭性”特征的临床和实验室证据。

A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.

作者信息

Chan Jasper Fuk-Woo, Lau Susanna Kar-Pui, Wong Sally Cheuk-Ying, To Kelvin Kai-Wang, So Simon Yung-Chun, Leung Sally Sau-Man, Chan Siu-Mang, Pang Chiu-Mei, Xiao Chenlu, Hung Ivan Fan-Ngai, Cheng Vincent Chi-Chung, Yuen Kwok-Yung, Woo Patrick Chiu-Yat

机构信息

State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, China.

Department of Microbiology, The University of Hong Kong, Hong Kong, China.

出版信息

Emerg Microbes Infect. 2016 Apr 20;5(4):e37. doi: 10.1038/emi.2016.31.

DOI:10.1038/emi.2016.31
PMID:27094904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4855073/
Abstract

In recent years, infections caused by Aspergillus sp. have become an emerging focus of clinical microbiology and infectious disease, as the number of patients infected with Aspergillus sp. has increased markedly. Although chronic pulmonary aspergillosis (CPA) is considered a 'semi-invasive' or 'intermediate' disease, little data are available for the direct comparison of CPA with invasive pulmonary aspergillosis (IPA) and pulmonary aspergilloma (PA) to quantify invasiveness. In this study, we compared the characteristics of CPA with those of IPA and PA among hospitalized patients over a 10-year period. A total of 29, 51 and 31 cases of CPA, IPA and PA, respectively, were included. An increasing trend in galactomannan antigen seropositivity rate from PA (24.1%) to CPA (35.7%) to IPA (54.9%) and an opposite trend for anti-Aspergillus antibody (PA (71.0%) to CPA (45.8%) to IPA (7.1%)) were observed. Eight percent of CPA patients were infected with more than one Aspergillus sp. The survival rate of the CPA group also fell between the survival rate of PA and IPA, confirming the intermediate severity of CPA. The survival rate of the CPA group became significantly higher than that of the IPA group from day 180 onwards until 2 years after admission (P<0.05). The survival rate of the CPA group remained lower than that of the PA group from day 30 onwards until 2 years after admission. Poor prognostic factors for CPA included older age (P=0.019), higher total leukocyte count (P=0.011) and higher neutrophil count (P=0.012) on admission. This study provided clinical and laboratory evidence for the semi-invasive properties of CPA.

摘要

近年来,随着感染曲霉属的患者数量显著增加,曲霉属引起的感染已成为临床微生物学和传染病领域新出现的关注焦点。尽管慢性肺曲霉病(CPA)被认为是一种“半侵袭性”或“中间型”疾病,但关于将CPA与侵袭性肺曲霉病(IPA)和肺曲菌球(PA)进行直接比较以量化侵袭性的数据却很少。在本研究中,我们比较了10年间住院患者中CPA与IPA和PA的特征。分别纳入了29例CPA、51例IPA和31例PA患者。观察到从PA(24.1%)到CPA(35.7%)再到IPA(54.9%),半乳甘露聚糖抗原血清阳性率呈上升趋势,而抗曲霉抗体则呈相反趋势(PA(71.0%)到CPA(45.8%)再到IPA(7.1%))。8%的CPA患者感染了不止一种曲霉属。CPA组的生存率也介于PA组和IPA组之间,证实了CPA的病情严重程度处于中间水平。从入院后第180天直至入院后2年,CPA组的生存率显著高于IPA组(P<0.05)。从入院后第30天直至入院后2年,CPA组的生存率一直低于PA组。CPA的不良预后因素包括入院时年龄较大(P=0.019)、总白细胞计数较高(P=0.011)和中性粒细胞计数较高(P=0.012)。本研究为CPA的半侵袭性特性提供了临床和实验室证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/4855073/657cd016429b/emi201631f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/4855073/ff78fea3c5da/emi201631f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/4855073/657cd016429b/emi201631f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/4855073/ff78fea3c5da/emi201631f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/4855073/657cd016429b/emi201631f2.jpg

相似文献

1
A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.一项为期10年的研究揭示了慢性肺曲霉病“半侵袭性”特征的临床和实验室证据。
Emerg Microbes Infect. 2016 Apr 20;5(4):e37. doi: 10.1038/emi.2016.31.
2
Clinical characteristics and prognosis of chronic pulmonary aspergillosis.慢性肺曲霉病的临床特征和预后。
Respir Med. 2012 May;106(5):724-9. doi: 10.1016/j.rmed.2012.01.014. Epub 2012 Feb 19.
3
Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.血清曲霉 IgG 抗体检测在诊断非粒细胞减少症患者侵袭性和慢性肺曲霉病中的潜在价值。
BMC Pulm Med. 2020 Apr 15;20(1):89. doi: 10.1186/s12890-020-1125-y.
4
Evaluation of -Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.应用于血清和支气管肺泡灌洗液的半乳甘露聚糖检测试验在慢性肺曲霉病诊断中的评价。
J Clin Microbiol. 2019 Apr 26;57(5). doi: 10.1128/JCM.00095-19. Print 2019 May.
5
Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.中国慢性肺曲霉病患者的临床特征和转归:一项回顾性、观察性研究。
J Mycol Med. 2020 Dec;30(4):101041. doi: 10.1016/j.mycmed.2020.101041. Epub 2020 Aug 28.
6
[Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].[曲霉相关的呼吸道疾病与慢性阻塞性肺疾病:诊断挑战]
Rev Mal Respir. 2020 Apr;37(4):308-319. doi: 10.1016/j.rmr.2020.02.011. Epub 2020 Apr 10.
7
Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.从呼吸道样本中分离出曲霉菌属的患者的临床特征:慢性肺曲霉病与定植的比较。
Respir Investig. 2016 Mar;54(2):92-7. doi: 10.1016/j.resinv.2015.08.007. Epub 2015 Oct 20.
8
Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.半乳甘露聚糖酶联免疫吸附测定(ELISA)和聚合酶链反应(PCR)在变应性支气管肺曲霉病(ABPA)和慢性肺曲霉病(CPA)患者痰液中的比较表现
J Microbiol Methods. 2017 Sep;140:32-39. doi: 10.1016/j.mimet.2017.06.016. Epub 2017 Jun 21.
9
The spectrum of pulmonary aspergillosis.肺部曲霉菌病的光谱。
Respir Med. 2018 Aug;141:121-131. doi: 10.1016/j.rmed.2018.06.029. Epub 2018 Jul 3.
10
Detection of DNA in BALF by Real-time PCR and Galactomannan Antigen for the Early Diagnosis of Chronic Pulmonary Aspergillosis.实时 PCR 和半乳甘露聚糖抗原检测 BALF 中的 DNA 对慢性肺曲霉病的早期诊断。
Ann Clin Lab Sci. 2021 Sep;51(5):698-704.

引用本文的文献

1
Automatic identification of clinically important species by artificial intelligence-based image recognition: proof-of-concept study.基于人工智能图像识别的临床重要物种自动识别:概念验证研究。
Emerg Microbes Infect. 2025 Dec;14(1):2434573. doi: 10.1080/22221751.2024.2434573. Epub 2024 Dec 9.
2
Three-Month Mortality in Nonhaematological Patients with Chronic Pulmonary Aspergillosis: Differences between Subtypes.非血液系统慢性肺曲霉病患者的三个月死亡率:各亚型之间的差异
J Fungi (Basel). 2024 Oct 10;10(10):706. doi: 10.3390/jof10100706.
3
Clinical and Microbiological Characteristics of Aspergillosis at a Chinese Tertiary Teaching Hospital.

本文引用的文献

1
Metabolomics Analysis Reveals Specific Novel Tetrapeptide and Potential Anti-Inflammatory Metabolites in Pathogenic Aspergillus species.代谢组学分析揭示了致病性曲霉菌种中特定的新型四肽和潜在的抗炎代谢物。
Int J Mol Sci. 2015 Jun 17;16(6):13850-67. doi: 10.3390/ijms160613850.
2
Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus: characterization by internal transcribed spacer, β-Tubulin, and calmodulin gene sequencing, metabolic fingerprinting, and matrix-assisted laser desorption ionization-time of flight mass spectrometry.将溜曲霉和棕曲霉误鉴定为黄曲霉:通过内转录间隔区、β-微管蛋白和钙调蛋白基因测序、代谢指纹分析以及基质辅助激光解吸电离飞行时间质谱进行鉴定。
J Clin Microbiol. 2014 Apr;52(4):1153-60. doi: 10.1128/JCM.03258-13. Epub 2014 Jan 22.
3
中国一家三级教学医院曲霉病的临床和微生物学特征
Infect Drug Resist. 2022 Dec 11;15:7249-7257. doi: 10.2147/IDR.S391069. eCollection 2022.
4
A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.一项评估播散性脑曲霉病、白血病和淋巴瘤及其各自治疗方法之间关系的系统评价。
J Fungi (Basel). 2022 Jul 11;8(7):722. doi: 10.3390/jof8070722.
5
Chronic Pulmonary Aspergillosis: Burden, Clinical Characteristics and Treatment Outcomes at a Large Australian Tertiary Hospital.慢性肺曲霉病:澳大利亚一家大型三级医院的疾病负担、临床特征及治疗结果
J Fungi (Basel). 2022 Jan 25;8(2):110. doi: 10.3390/jof8020110.
6
The Gβ-like Protein CpcB Affects Sexual Development, Response to Oxidative Stress and Phagocytosis by Alveolar Macrophages in .类Gβ蛋白CpcB影响[具体生物名称]的性发育、对氧化应激的反应以及肺泡巨噬细胞的吞噬作用。
J Fungi (Basel). 2022 Jan 6;8(1):56. doi: 10.3390/jof8010056.
7
Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan.慢性肺曲霉病的预后因素:来自日本的 264 例回顾性队列研究。
PLoS One. 2021 Apr 1;16(4):e0249455. doi: 10.1371/journal.pone.0249455. eCollection 2021.
8
Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.慢性肺曲霉病:给资源有限且无真菌学家的环境中临床医生的笔记
J Fungi (Basel). 2020 Jun 2;6(2):75. doi: 10.3390/jof6020075.
Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis.长期抗真菌治疗可改善慢性肺部曲霉病患者的健康状况:一项纵向分析。
Clin Infect Dis. 2013 Sep;57(6):828-35. doi: 10.1093/cid/cit411. Epub 2013 Jun 20.
4
Pulmonary aspergillosis: a clinical review.肺曲霉病:临床综述。
Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011.
5
Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.无预设影像学发现的疑似侵袭性曲霉病:纳入一种新曲霉病分类的建议及其对研究新型疗法的影响。
Clin Infect Dis. 2010 Dec 1;51(11):1273-80. doi: 10.1086/657065. Epub 2010 Oct 29.
6
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组(EORTC/MSG)共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
7
Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature.慢性阻塞性肺疾病患者的侵袭性肺曲霉病:5例报告及文献系统综述
Chron Respir Dis. 2008;5(1):19-27. doi: 10.1177/1479972307085637.
8
Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.针对曲霉菌细胞壁抗原的特征明确的单克隆抗体可提高免疫测定的特异性和灵敏度。
Clin Vaccine Immunol. 2008 Feb;15(2):194-202. doi: 10.1128/CVI.00362-07. Epub 2007 Nov 21.
9
Invasive aspergillosis in critically ill patients without malignancy.无恶性肿瘤的重症患者中的侵袭性曲霉病
Am J Respir Crit Care Med. 2004 Sep 15;170(6):621-5. doi: 10.1164/rccm.200401-093OC. Epub 2004 Jun 30.
10
Association of presence of Aspergillus antibodies with hemoptysis in patients with old tuberculosis or bronchiectasis but no radiologically visible mycetoma.曲霉抗体的存在与陈旧性肺结核或支气管扩张但影像学上无可见真菌球患者咯血的相关性。
J Clin Microbiol. 2004 Feb;42(2):665-9. doi: 10.1128/JCM.42.2.665-669.2004.